Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Published Online: 2016-08-?
Journal: The Lancet Oncology•Publisher: Elsevier BV
Authors: Alison Birtle•Andrew Stockdale•Annie Gao•Chris Parker•Chris South•Christopher Scrase•Clare Cruickshank•Clare Griffin•David Bloomfield•David Dearnaley•Emma Hall•Helen Mayles•Helen Mossop•Helen Patterson•Isabel Syndikus•Jean Tremlett•Joe M O'Sullivan•John Graham•John Logue•John Staffurth•Julia Pugh•Julian Money-Kyrle•Margaret Bidmead•Miguel Panades•Olivia Naismith•Peter Kirkbride•Shama Hassan•Vincent Khoo•Zafar Malik
